Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in Rheumatoid Arthritis
NCT00071812Phase 2Completed
- Sponsor
- Human Genome Sciences
- Start
- Dec 2003
- Primary completion
- Jan 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in rheumatoid arthritis (RA), sponsored by Human Genome Sciences. Started Dec 2003; status: completed.
02
Drugs
belimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00071812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071812.